Five patents currently held, every record listed here
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
The next term ends in Feb 2034. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
Feb 2034
Next term end
5
Patent families
When these terms end
Each bar runs from grant to computed term end. 2018 to 2036.
US 10,472,380
Platinum Compounds Having a Heterocycle Ligand, Nanoparticles, and Uses Thereof
Jul 16, 2034
20222026203020342036
Every computed term in this portfolio is shown above.Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2035 · High confidence
Also notable
Ends Feb 2034 · Low confidence
Also notable
Ends Jun 2036 · High confidence
Platinum Compounds, Compositions, and Uses Thereof
US 10,322,137
The newest of the three, granted 2019. It anchors the portfolio to 2035, later than anything else here.
Compounds, Compositions, and Methods for the Treatment of Cancers
US 10,111,853
A family of 6 related applications built on the 2018 grant. Protection runs to 2034.
Platinum Compounds, Compositions, and Uses Thereof
US 10,342,801
The newest of the three, granted 2019. It anchors the portfolio to 2036, later than anything else here.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 18, 2026The maintenance fee for Platinum Compounds, Compositions, and Uses Thereof (US 10,322,137) comes due Dec 18, 2026. Unpaid by Jun 21, 2027, it lapses early.
- 1 fee due Jan 9, 2027The maintenance fee for Platinum Compounds, Compositions, and Uses Thereof (US 10,342,801) comes due Jan 9, 2027. Unpaid by Jul 9, 2027, it lapses early.
- 1 fee due May 12, 2027The maintenance fee for Platinum Compounds Having a Heterocycle Ligand, Nanoparticles, and Uses Thereof (US 10,472,380) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
Grouped by real patent family, largest first, labeled by the earliest filing in each. No technology classification is inferred from titles.
| Platinum Compounds, Compositions, and Uses Thereof (2017) | 1 in force | to Jun 2036 |
| Platinum Compounds, Compositions, and Uses Thereof (2017) | 1 in force | to Jun 2035 |
| Platinum Compounds Having a Heterocycle Ligand, Nanoparticles, and Uses Thereof | 1 in force | to Jul 2034 |
| Compounds, Compositions, and Methods for the Treatment of Cancers (2016) | 1 in force | to Feb 2034 |
| Compounds, Compositions, and Methods for the Treatment of Cancers (2017) | 1 in force | to Feb 2034 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,111,853 | Compounds, Compositions, and Methods for the Treatment of Cancers Grace period ended · Low confidence | Grace period ended | Low confidence | |
| US 10,287,308 | Compounds, Compositions, and Methods for the Treatment of Cancers In force · High confidence | In force | High confidence | |
| US 10,472,380 | Platinum Compounds Having a Heterocycle Ligand, Nanoparticles, and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,322,137 | Platinum Compounds, Compositions, and Uses Thereof In force · High confidence | In force | High confidence | |
| US 10,342,801 | Platinum Compounds, Compositions, and Uses Thereof In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 6 patents ended · 9 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.